TL;DR
This study investigated how donor weight impacts adipose-derived stem cells (ASCs) using genetically identical twins with differing weights. They found that heavier donors' ASCs showed reduced potential for forming blood vessels (angiogenesis) but enhanced ability to differentiate into fat cells (adipogenesis), suggesting donor weight is a crucial factor for ASC-based therapies.
What Problem Does This Paper Address?
Adipose stromal/stem cells (ASCs) hold immense promise for regenerative medicine due to their ability to differentiate into various cell types and modulate immune responses. However, their clinical application hinges on understanding factors that influence their characteristics. While age, sex, and body mass index (BMI) are known to play a role, previous studies on the impact of obesity on ASCs have yielded contradictory results. This ambiguity makes it difficult to select optimal donors for cell-based therapies. This paper addresses this by using a unique resource: weight-discordant monozygotic (MZ) twin pairs. By comparing ASCs from genetically identical individuals with differing weights, the researchers can isolate the effect of acquired weight from genetic background, providing a clearer picture of how weight influences ASC behavior.
Methods
The researchers utilized a well-established methodology for isolating and culturing ASCs from subcutaneous adipose tissue. Key techniques included:
- Immunophenotyping: Flow cytometry was used to analyze the expression of specific cell surface markers (e.g., CD73, CD90, CD105) to confirm the mesenchymal stem cell (MSC)-like nature of the ASCs.
- Proliferation Assays: A Cell Counting Kit-8 (CCK-8) assay was employed to measure the rate at which ASCs divide over time.
- Differentiation Assays:
- Osteogenic differentiation: Assessed by measuring alkaline phosphatase (ALP) activity and gene expression (RUNX2, ALP), as well as mineralization using Alizarin Red staining.
- Adipogenic differentiation: Evaluated by Oil Red O (ORO) staining to visualize and quantify lipid droplet formation, and by measuring gene expression of adipogenic markers (PPARγ, AP2).
- Chondrogenic differentiation: Assessed using Alcian blue staining.
- Angiogenesis Potential Assay: ASCs were co-cultured with human umbilical vein endothelial cells (HUVECs), and the formation of new blood vessel-like structures was analyzed using collagen type IV staining and quantified with AngioTool.
- Immunogenicity and Immunosuppression Assays:
- Immunogenicity: Assessed via a one-way mixed lymphocyte reaction (MLR) to measure the ASCs' ability to stimulate peripheral blood mononuclear cell (PBMC) proliferation.
- Immunosuppression: Evaluated using a two-way MLR to determine the ASCs' capacity to suppress PBMC proliferation in direct and indirect co-cultures.
- Gene Expression Analysis: Quantitative real-time PCR (qRT-PCR) was used to measure the expression levels of key osteogenic, adipogenic, and inflammatory genes (RUNX2, ALP, PPARγ, AP2, IL-6, TNF).
The study design specifically leveraged the weight-discordant MZ twin pairs to compare outcomes within each pair, allowing for a genetically controlled comparison.
Datasets
The study utilized adipose tissue samples from five weight-discordant monozygotic (MZ) twin pairs. These pairs were selected from larger twin cohorts (FinnTwin16 and FinnTwin12) that had previously participated in metabolic studies. The selection criteria ensured a significant difference in Body Mass Index (BMI) within each pair (>3 kg/m²). No new datasets were introduced; rather, existing human donor material was used.
Key Insights and Ideas
- Genetics Trumps Weight for Basic ASC Properties: The study found that fundamental ASC characteristics like proliferation, immunophenotype, and chondrogenic differentiation were largely similar between leaner and heavier cotwins, suggesting that genetic background plays a more dominant role than acquired weight for these aspects.
- Weight Modulates Specific ASC Potentials: The most striking findings relate to how weight influences more specialized ASC functions. Heavier donors' ASCs showed a decreased ability to promote blood vessel formation (angiogenesis) but an increased capacity for fat cell differentiation (adipogenesis). This highlights a nuanced impact of weight, not a uniform impairment.
- Inflammatory Marker Link: Heavier cotwins exhibited significantly higher expression of the inflammatory marker TNF in their ASCs. This finding is particularly interesting as it correlates with their enhanced adipogenic potential, suggesting a potential molecular link between inflammation and fat differentiation in ASCs from heavier individuals.
- Unexpected Immunosuppressive Strength: Contrary to some previous studies suggesting obesity impairs ASC immunosuppression, this study found that heavier cotwins actually displayed superior immunosuppressive capacity in direct co-cultures. This challenges existing assumptions and underscores the complexity of obesity's effects.
- CD146 as a Potential Indicator: The expression of the surface marker CD146 was significantly lower in ASCs from heavier twins. CD146 is associated with pericytes and angiogenesis, providing a potential cellular mechanism for the observed reduced angiogenic potential in ASCs from heavier donors.
Key Results
- Metabolic Differences: Heavier cotwins consistently showed higher BMI, LDL cholesterol, hs-CRP, and leptin, along with impaired insulin sensitivity (HOMA-IR) and lower HDL cholesterol and adiponectin compared to their leaner cotwins.
- Surface Markers: While most MSC markers were similar, CD14 and CD146 expression was significantly higher in leaner cotwins.
- Proliferation: No significant difference in ASC proliferation was observed between leaner and heavier cotwins.
- Osteogenic Differentiation: ASCs from both groups showed similar osteogenic differentiation capacity, although a trend towards reduced mineralization was noted in heavier cotwins.
- Adipogenic Differentiation: ASCs from heavier cotwins demonstrated a significantly higher number of large lipid droplets (p=0.011), indicating enhanced adipogenic potential.
- Angiogenesis: Leaner cotwins' ASCs supported the formation of significantly larger vascular areas (p=0.039) and longer vasculature-like structures (p=0.031) compared to heavier cotwins.
- Immunogenicity: ASCs from both groups showed low immunogenicity.
- Immunosuppression: Heavier cotwins' ASCs exhibited significantly higher immunosuppressive capacity in direct co-cultures (p=0.017).
- Inflammatory Markers: TNF expression was significantly elevated in ASCs from heavier cotwins (p=0.015).
Limitations and Future Work
The authors acknowledge several limitations:
- Small Sample Size: The study used only five MZ twin pairs, which, while providing a unique genetic control, limits the generalizability of the findings.
- Variability in Donor Material: One ASC donor cell line did not differentiate well and detached repeatedly, suggesting that the quality of the starting material can influence cell behavior and potentially reduce the number of donors available for certain analyses.
- Early Culture Effects: The observed differences might be more pronounced in early-stage cultures and could potentially diminish with longer-term expansion.
Future work could focus on:
- Larger Cohorts: Replicating these findings in larger cohorts of weight-discordant individuals.
- Mechanism Elucidation: Further investigating the molecular mechanisms underlying the observed differences in adipogenesis, angiogenesis, and immunosuppression, particularly the role of TNF and CD146.
- In Vivo Studies: Translating these in vitro findings into in vivo models to assess the functional consequences of donor weight on ASC therapeutic efficacy.
- Long-Term Culture Effects: Examining how prolonged in vitro culture impacts the weight-dependent ASC characteristics.
Summary updated